The Short Bowel Syndrome Market was characterized by intense competition and significant research and development activities. Key pharmaceutical companies and biotech firms were striving to gain a competitive edge in this niche market segment. Some of the prominent players in the SBS market included Shire (a Takeda company), Zealand Pharma, OxThera, and Emmaus Life Sciences.
These companies...
0 Commentarios
0 Acciones
1966 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian